{{Infobox company
| logo             = Illumina logo.svg
| type             = [[上市公司|上市公司]]
| traded_as        = {{NASDAQ|ILMN}}<br>[[NASDAQ-100|NASDAQ-100 Component]]<br>[[S&P_500|S&P 500 Component]]
| foundation = 1998年
| founder          = {{unbulleted list|David Walt|Larry Bock|John Stuelpnagel|Anthony Czarnik|Mark Chee}}
| location_city = [[圣地亚哥_(加利福尼亚州)|圣地亚哥]]
| location_country = [[美国|美国]]
| location = 
| locations = 
| area_served = 
| key_people = 
| industry = [[生物科技|生物科技]]
| products = 
| services = 
| revenue = {{increase}} 27.52亿美元 <small>(2017)</small><ref name="IlluminaFY2017">{{Citation|url=https://www.illumina.com/content/dam/illumina-marketing/documents/company/investor-relations/Q417_Illumina_EarningsRelease.pdf|title=Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017|date=2018-01-30|access-date=2018-06-06|publisher=Illumina, Inc.|archive-date=2018-06-12|archive-url=https://web.archive.org/web/20180612140529/https://www.illumina.com/content/dam/illumina-marketing/documents/company/investor-relations/Q417_Illumina_EarningsRelease.pdf|dead-url=no}}</ref>
| operating_income = {{increase}} 8.75亿美元 <small>(2017)</small><ref name="IlluminaFY2017" />
| net_income = {{increase}} 7.26亿美元  <small>(2017)</small><ref name="IlluminaFY2017" />|
| owner = 
| num_employees = 
| parent = 
| divisions = 
| subsid = 
| caption = 
| homepage = {{URL|http://www.illumina.com/}}
| footnotes = 
| intl = 
}}
'''Illumina'''是美国的一家生物科技公司，成立于1998年，总部设于[[加利福尼亚州|加利福尼亚州]][[圣地亚哥_(加利福尼亚州)|圣地亚哥]]。它在巴西、英国、荷兰、中国、新加坡、日本、澳大利亚也设有分部。其员工超过3000人，2013年总收入达14.2亿。<ref>{{cite web|url=http://www.illumina.com.cn/company/about-us/about-facts.aspx|title=Illumina about-facts|format=|work=|accessdate=|deadurl=yes|archiveurl=https://web.archive.org/web/20141027145458/http://www.illumina.com.cn/company/about-us/about-facts.aspx|archivedate=2014-10-27}}</ref>该公司专注于生物信息分析，提供有关SNP基因分型、[[拷贝数变异|拷贝数变异]]（CNV）、[[基因组测序|基因组测序]]、[[DNA甲基化|DNA甲基化]]研究、[[转录组分析|转录组分析]]、[[基因表达谱分析|基因表达谱分析]]相关的服务。<ref>{{cite web|url=http://www.illumina.com.cn/company/about-us.aspx|title=Illumina about-us|format=|work=|accessdate=|deadurl=yes|archiveurl=https://web.archive.org/web/20141027150823/http://www.illumina.com.cn/company/about-us.aspx|archivedate=2014-10-27}}</ref>如今的Illumina已经占有了基因组测序领域70%的市场份额，在2014年还被《MIT技术评论》选为年度50家最聪明公司第一位。<ref>{{cite web |url=http://www.technologyreview.com/featuredstory/524531/why-illumina-is-no-1/ |title=Top of the 50 Smartest Company List: Illumina | MIT Technology Review |format= |work= |accessdate= |archive-date=2015-12-11 |archive-url=https://web.archive.org/web/20151211020908/http://www.technologyreview.com/featuredstory/524531/why-illumina-is-no-1/ }}</ref>

== 发展历程 ==
Illumina由David Walt，Larry Bock，John Stuelpnagel，Anthony Czarnik和Mark Chee于1998年4月创立。在与[[风险投资|风险投资]]公司CW Group合作时，Bock和Stuelpnagel在塔夫茨大学发现了Illumina的BeadArray技术，并就该技术的独家许可进行了谈判。1999年，Illumina收购了Spyder Instruments（由Michal Lebl，Richard Houghten和Jutta Eichler创立），用于高通量合成技术。Illumina于2000年7月完成首次公开募股。

Illumina 于2001年开始提供单核苷酸多态性（SNP）基因分型服务，并于2002年推出了第一个使用GoldenGate基因分型技术的系统Illumina BeadLab。Illumina目前提供基于微阵列的产品和服务，用于扩展遗传分析测序，包括SNP基因分型，基因表达和蛋白质分析。Illumina的技术被广泛的学术，政府，制药，生物技术和全球其他领先机构所采用。

2007年1月26日，Illumina完成对[[Solexa|Solexa]]公司的收购.Solexa于1998年6月由Shankar Balasubramanian和David Klenerman成立，负责开发和商业化由剑桥大学创始人发明的基因组测序技术。Solexa INC成立于2005年，当时Solexa Ltd变成了海沃德的 Lynx Therapeutics 。<ref>{{Cite web|url=https://www.illumina.com/technology/next-generation-sequencing/solexa-technology.html|title=History of Illumina Sequencing and Solexa Technology|accessdate=2018-08-23|work=www.illumina.com|archive-date=2017-02-02|archive-url=https://web.archive.org/web/20170202034425/https://www.illumina.com/technology/next-generation-sequencing/solexa-technology.html|dead-url=no}}</ref>Illumina还使用了[[DNA集落测序技术|DNA集落测序技术]]，该技术由Pascal Mayer和Laurent Farinelli于1997年发明<ref>{{Cite web|url=https://www.lens.org/lens|title=WO_1998_044151_A1 The Lens - Free & Open Patent and Scholarly Search|accessdate=2018-08-23|work=The Lens - Free & Open Patent and Scholarly Search|archive-date=2020-12-07|archive-url=https://web.archive.org/web/20201207171234/https://www.lens.org/lens|dead-url=no}}</ref>，并于2004年被Solexa从[[Manteia_Predictive_Medicine|Manteia Predictive Medicine]]公司收购。它被用于进行一系列分析，包括[[全基因组重测序|全基因组重测序]]，[[基因表达分析|基因表达分析]]和[[小核糖核酸|小核糖核酸]]（RNA）分析。

2009年6月，Illumina宣布推出自己的个人全基因组测序服务，深度为30X，每个基因组48,000美元（约329,601元人民币），一年后将价格降至19,500美元。<ref>{{Cite news|url=https://www.forbes.com/2010/09/16/careers-life-sciences-intelligent-technology-illumina.html|title=Illumina CEO On The Lunch That Launched Him|last=Dolan|first=Kerry A.|newspaper=Forbes|accessdate=2018-08-23|language=en|archive-date=2017-12-01|archive-url=https://web.archive.org/web/20171201044435/https://www.forbes.com/2010/09/16/careers-life-sciences-intelligent-technology-illumina.html|dead-url=no}}</ref><ref>{{Cite web|url=http://www.bio-itworld.com/news/06/11/09/illumina-personal-genome-sequencing-service.html|title=Bio-IT World|accessdate=2018-08-23|work=www.bio-itworld.com|language=en-us|archive-date=2020-08-01|archive-url=https://web.archive.org/web/20200801215755/http://www.bio-itworld.com/news/06/11/09/illumina-personal-genome-sequencing-service.html|dead-url=yes}}</ref>截至2011年5月，Illumina将价格降至4,000美元。<ref>{{Cite web|url=http://www.signonsandiego.com/news/2011/may/09/illumina-drops-human-sequencing-price-4000|title=|accessdate=|author=|date=|publisher=|archive-date=2011-12-09|archive-url=https://web.archive.org/web/20111209105537/http://www.signonsandiego.com/news/2011/may/09/illumina-drops-human-sequencing-price-4000/|dead-url=no}}</ref>

截至2010年，Illumina仅销售标记为“仅供研究使用”的仪器; 2010年初，Illumina获得了FDA批准其BeadXpress系统用于临床试验。<ref>{{Cite news|url=https://www.genomeweb.com/arrays/fda-clears-illuminas-beadxpress-system-clinical-use|title=FDA Clears Illumina's BeadXpress System for Clinical Use|newspaper=GenomeWeb|accessdate=2018-08-23|language=en|archive-date=2020-11-04|archive-url=https://web.archive.org/web/20201104153445/https://www.genomeweb.com/arrays/fda-clears-illuminas-beadxpress-system-clinical-use|dead-url=no}}</ref><ref>{{Cite web|url=https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K093128|title=510(k) Premarket Notification|accessdate=2018-08-23|work=www.accessdata.fda.gov|archive-date=2020-11-04|archive-url=https://web.archive.org/web/20201104030907/https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K093128|dead-url=no}}</ref>这是该公司当时开设自己的CLIA实验室并开始提供临床基因检测的战略的一部分。

2011年1月11日，Illumina公司收购总部设在[[威斯康星州|威斯康星州]][[麦迪逊|麦迪逊]]的[[震中生物技术|震中生物技术]]，<ref>{{Cite web|url=http://investor.illumina.com/phoenix.zhtml?c=121127&p=irol-newsArticle&ID=1515240|title=Illumina .::. Investor Relations News Release|accessdate=2018-08-23|work=investor.illumina.com|archive-date=2013-11-21|archive-url=https://archive.today/20131121215913/http://investor.illumina.com/phoenix.zhtml?c=121127&p=irol-newsArticle&ID=1515240|dead-url=yes}}</ref>

2012年1月25日，[[罗氏公司|罗氏公司]]试图收购Illumina公司，但遭到拒绝。

2014年，该公司发布了一项价值数百万美元的产品HiSeq X Ten，它预测将提供1000美元/基因组的大规模全基因组测序。该公司声称，截止到当时，40台这样的设备能比其他所有设备家加起来测的全基因组顺序都要多<ref>{{Cite news|url=http://www.technologyreview.com/news/523601/does-illumina-have-the-first-1000-genome|title=New High-End DNA Sequencing Machine Is 10 Times Faster Than Predecessors|last=Rojahn|first=Susan Young|newspaper=MIT Technology Review|accessdate=2018-08-23|language=en|archive-date=2015-12-08|archive-url=https://web.archive.org/web/20151208222623/http://www.technologyreview.com/news/523601/does-illumina-have-the-first-1000-genome/}}</ref>2014年1月，Illumina已经拥有70％的基因组测序机市场。<ref>{{Cite news|url=http://www.technologyreview.com/featuredstory/524531/why-illumina-is-no-1/|title=Illumina is No. 1 on the MIT Technology Review list of the 50 Smartest Companies|last=Zimmerman|first=Eilene|newspaper=MIT Technology Review|accessdate=2018-08-23|language=en|archive-date=2015-12-11|archive-url=https://web.archive.org/web/20151211020908/http://www.technologyreview.com/featuredstory/524531/why-illumina-is-no-1/}}</ref>Illumina的机器拥有所有DNA数据的90％以上。<ref>{{Cite news|url=http://www.technologyreview.com/news/531091/emtech-illumina-says-228000-human-genomes-will-be-sequenced-this-year/|title=EmTech: Record Number of Genomes Sequenced in 2014|last=Regalado|first=Antonio|newspaper=MIT Technology Review|accessdate=2018-08-23|language=en|archive-date=2015-12-26|archive-url=https://web.archive.org/web/20151226182622/http://www.technologyreview.com/news/531091/emtech-illumina-says-228000-human-genomes-will-be-sequenced-this-year/}}</ref>

2016年7月5日，Jay Flatley自1999年以来一直担任首席执行官，担任董事会执行主席。Francis deSouza担任总裁兼首席执行官，并继续担任Illumina董事会成员。<ref>{{Cite web|url=http://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=2146525|title=Press Release|accessdate=2018-08-23|work=www.illumina.com|archive-date=2020-02-18|archive-url=https://web.archive.org/web/20200218125031/https://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=2146525|dead-url=no}}</ref><ref>{{Cite journal|title=Mary Ann Liebert|url=https://en.wikipedia.org/w/index.php?title=Mary_Ann_Liebert&oldid=852951018|date=2018-08-01|journal=Wikipedia|language=en}}</ref>

2015年底，Illumina出售了GRAIL公司，专注于血液中癌症肿瘤的血液检测。该公司计划在2017年筹集10亿美元的第二轮融资，并获得[[比尔盖茨|比尔盖茨]]和[[杰夫贝索斯|杰夫贝索斯]]投资1亿美元的A轮融资的资金，并且Illumina在Grail保持20％的持股比例。<ref>{{Cite news|url=https://www.forbes.com/sites/matthewherper/2017/01/05/grail-which-aims-to-invent-blood-test-to-detect-cancer-to-raise-1-billion/#7bfbdc393792|title=Company Will Raise $1 Billion To Create Blood Test To Detect Cancer|last=Herper|first=Matthew|newspaper=Forbes|accessdate=2018-08-23|language=en|archive-date=2020-12-06|archive-url=https://web.archive.org/web/20201206042922/https://www.forbes.com/sites/matthewherper/2017/01/05/grail-which-aims-to-invent-blood-test-to-detect-cancer-to-raise-1-billion/#7bfbdc393792|dead-url=no}}</ref>该公司正在与明尼苏达州和威斯康星州的定期乳房X光检查中的超过120,000名妇女进行血液测试，并与梅奥诊所合作。Grail公司使用Illumina测序技术进行测试。<ref>{{Cite news|url=http://www.startribune.com/mayo-scientists-on-the-trail-of-a-pan-cancer-test/420819403/|title=Mayo Clinc scientists on the trail of a 'pan cancer' test|newspaper=Star Tribune|accessdate=2018-08-23|archive-date=2020-08-09|archive-url=https://web.archive.org/web/20200809062726/https://www.startribune.com/mayo-scientists-on-the-trail-of-a-pan-cancer-test/420819403/|dead-url=no}}</ref>该公司计划到2019年推出测试，每个人的成本为500美元。<ref>{{Cite news|url=https://www.fool.com/investing/general/2016/05/29/are-jeff-bezos-and-bill-gates-wrong-about-illumina.aspx|title=Are Jeff Bezos and Bill Gates Wrong About Illumina?|last=Swanson|first=Cheryl|newspaper=The Motley Fool|accessdate=2018-08-23|language=en|archive-date=2020-10-25|archive-url=https://web.archive.org/web/20201025001953/https://www.fool.com/investing/general/2016/05/29/are-jeff-bezos-and-bill-gates-wrong-about-illumina.aspx|dead-url=no}}</ref>

==参考资料==
{{reflist}}

== 外部链接 ==
{{commons category|Illumina (company)}}
* {{En}}[http://www.illumina.com Illumina's Company Website]{{Wayback|url=http://www.illumina.com/ |date=20170315024356 }}
* {{En}}[http://www.dnavision.com/pharmacogenetics/illumina_genotyping.php DNAVision]{{Wayback|url=http://www.dnavision.com/pharmacogenetics/illumina_genotyping.php |date=20150923215457 }} - Illumina official service provider.
* {{En}}[http://www.genelogic.com/ Gene Logic - performs research based on Illumina's Golden gate assay]{{Wayback|url=http://www.genelogic.com/ |date=20180805180451 }}

{{NASDAQ-100}}

[[Category:納斯達克100指數成分股|Category:納斯達克100指數成分股]]
[[Category:納斯達克上市公司|Category:納斯達克上市公司]]
[[Category:1998年成立的公司|Category:1998年成立的公司]]
[[Category:微阵列|Category:微阵列]]
[[Category:DNA测序|Category:DNA测序]]